Correlation Between Bristol Myers and Grifols SA

Can any of the company-specific risk be diversified away by investing in both Bristol Myers and Grifols SA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and Grifols SA into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bristol Myers Squibb and Grifols SA ADR, you can compare the effects of market volatilities on Bristol Myers and Grifols SA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of Grifols SA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and Grifols SA.

Diversification Opportunities for Bristol Myers and Grifols SA

-0.52

Correlation Coefficient

Bristol Myers  Grifols SA

Excellent diversification

The 3 months correlation between Bristol and Grifols is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and Grifols SA ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Grifols SA ADR and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with Grifols SA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Grifols SA ADR has no effect on the direction of Bristol Myers i.e., Bristol Myers and Grifols SA go up and down completely randomly.

Pair Corralation between Bristol Myers and Grifols SA

Considering the 90-day investment horizon Bristol Myers Squibb is expected to under-perform the Grifols SA. But the stock apears to be less risky and, when comparing its historical volatility, Bristol Myers Squibb is 3.17 times less risky than Grifols SA. The stock trades about -0.1 of its potential returns per unit of risk. The Grifols SA ADR is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  721.00  in Grifols SA ADR on January 20, 2024 and sell it today you would lose (67.00) from holding Grifols SA ADR or give up 9.29% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Bristol Myers Squibb  vs.  Grifols SA ADR

Bristol Myers Squibb

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Bristol Myers Squibb has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong primary indicators, Bristol Myers is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Grifols SA ADR

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Grifols SA ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable technical and fundamental indicators, Grifols SA is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Bristol Myers and Grifols SA

The main advantage of trading using opposite Bristol Myers and Grifols SA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, Grifols SA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Grifols SA will offset losses from the drop in Grifols SA's long position.

The idea behind Bristol Myers Squibb and Grifols SA ADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.